J. U. Gutterman

2.8k total citations
58 papers, 2.2k citations indexed

About

J. U. Gutterman is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, J. U. Gutterman has authored 58 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 15 papers in Hematology and 15 papers in Immunology. Recurrent topics in J. U. Gutterman's work include Chronic Lymphocytic Leukemia Research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). J. U. Gutterman is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). J. U. Gutterman collaborates with scholars based in United States, United Kingdom and Spain. J. U. Gutterman's co-authors include Moshe Talpaz, Gerald P. Bodey, Jorge R. Quesada, E. M. Hersh, Giora M. Mavligit, Emil J. Freireich, David A. Swanson, Adan Rios, Patrick W. Trown and Razelle Kurzrock and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

J. U. Gutterman

55 papers receiving 2.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
J. U. Gutterman 880 671 518 430 376 58 2.2k
Michel Symann 1.3k 1.4× 495 0.7× 371 0.7× 427 1.0× 242 0.6× 95 2.2k
William H. Knospe 480 0.5× 699 1.0× 330 0.6× 325 0.8× 648 1.7× 55 1.8k
M. Andreeff 680 0.8× 1.0k 1.5× 818 1.6× 371 0.9× 881 2.3× 38 2.4k
C. De Wolf‐Peeters 821 0.9× 533 0.8× 373 0.7× 595 1.4× 490 1.3× 78 2.8k
P Hervé 528 0.6× 1.5k 2.3× 333 0.6× 631 1.5× 478 1.3× 133 2.5k
Markus Wiesneth 802 0.9× 982 1.5× 494 1.0× 903 2.1× 412 1.1× 118 2.7k
Alexander Kiani 1.1k 1.2× 935 1.4× 680 1.3× 623 1.4× 394 1.0× 78 2.7k
MF Greaves 407 0.5× 726 1.1× 829 1.6× 450 1.0× 320 0.9× 26 2.3k
Paul G. Schlegel 600 0.7× 490 0.7× 435 0.8× 480 1.1× 376 1.0× 56 1.8k
H. Poliwoda 660 0.8× 344 0.5× 332 0.6× 384 0.9× 118 0.3× 139 1.8k

Countries citing papers authored by J. U. Gutterman

Since Specialization
Citations

This map shows the geographic impact of J. U. Gutterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. U. Gutterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. U. Gutterman more than expected).

Fields of papers citing papers by J. U. Gutterman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. U. Gutterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. U. Gutterman. The network helps show where J. U. Gutterman may publish in the future.

Co-authorship network of co-authors of J. U. Gutterman

This figure shows the co-authorship network connecting the top 25 collaborators of J. U. Gutterman. A scholar is included among the top collaborators of J. U. Gutterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. U. Gutterman. J. U. Gutterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jenkins, Jan, et al.. (2001). Pilot study of vitaxin?an angiogenesis inhibitor?in patients with advanced leiomyosarcomas. Cancer. 92(5). 1347–1348. 74 indexed citations
2.
Bodey, Gerald P., E. Anaissie, J. U. Gutterman, & Saroj Vadhan‐Raj. (1993). Role of Granulocyte-Macrophage Colony-Stimulating Factor as Adjuvant Therapy for Fungal Infection in Patients with Cancer. Clinical Infectious Diseases. 17(4). 705–707. 101 indexed citations
3.
Wetzler, Meir, Zeev Estrov, Moshe Talpaz, et al.. (1993). Granulocyte‐macrophage colony‐stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma. Journal of Internal Medicine. 234(4). 417–420. 35 indexed citations
4.
McLaughlin, Peter, Fernando Cabanillas, Fredrick B. Hagemeister, et al.. (1993). CHOP-Bleo plus interferon for stage IV low-grade lymphoma. Annals of Oncology. 4(3). 205–211. 46 indexed citations
5.
Kurzrock, Razelle, Moshe Talpaz, & J. U. Gutterman. (1992). Very low doses of GM-CSF administered alone or with erythropoietin in a plastic anemia. The American Journal of Medicine. 93(1). 41–48. 23 indexed citations
6.
Buzdar, Aman U., Gabriel N. Hortobágyi, Shu‐Wan Kau, et al.. (1992). Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer.. Journal of Clinical Oncology. 10(10). 1540–1546. 28 indexed citations
7.
Talpaz, Moshe, Michael J. Keating, Elihu H. Estey, et al.. (1991). Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Cancer. 68(6). 1201–1207. 34 indexed citations
8.
Dhingra, Kapil, et al.. (1991). A phase I trial of recombinant alpha-2a Interferon (Roferon-A) with weekly cisplatinum. Investigational New Drugs. 9(1). 37–39. 13 indexed citations
9.
Alexanian, Raymond, Bart Barlogie, & J. U. Gutterman. (1991). α-Interferon Combination Therapy of Resistant Myeloma. American Journal of Clinical Oncology. 14(3). 188–192. 17 indexed citations
10.
Murray, James L., Eugenie Kleinerman, Joan E. Cunningham, et al.. (1989). Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients.. Journal of Clinical Oncology. 7(12). 1915–1925. 98 indexed citations
11.
Kleinerman, Eugenie S., et al.. (1988). Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.. PubMed. 48(9). 2604–9. 37 indexed citations
12.
Shtalrid, M, Moshe Talpaz, Mark Blick, et al.. (1988). Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.. Journal of Clinical Oncology. 6(10). 1569–1575. 38 indexed citations
13.
Rosenblum, M. G., L. Lamki, James L. Murray, Dennis J. Carlo, & J. U. Gutterman. (1988). Interferon-Induced Changes in Pharmacokinetics and Tumor Uptake of 111In-Labeled Antimelanoma Antibody 96.5 in Melanoma Patients. JNCI Journal of the National Cancer Institute. 80(3). 160–165. 54 indexed citations
14.
Kurzrock, Razelle, Mordechai Shtalrid, J. U. Gutterman, et al.. (1987). Molecular analysis of chromosome 22 breakpoints in adult Philadelphia-positive acute lymphoblastic leukaemia. British Journal of Haematology. 67(1). 55–59. 29 indexed citations
15.
Talpaz, Moshe, Hagop M. Kantarjian, K. B. McCredie, et al.. (1987). Therapy of chronic myelogenous leukemia. Cancer. 59(S3). 664–667. 21 indexed citations
16.
Rosenblum, Michael G. & J. U. Gutterman. (1985). Human leukocyte interferon (IFN) and mismatched, double-stranded RNA (dsRNA): synergistic antiproliferative activity in vitro. Proceedings of the American Association for Cancer Research. 26. 1 indexed citations
17.
Verma, D. S., Sundar Jagannath, & J. U. Gutterman. (1984). Human immune interferon and leukocyte interferon divert granulocyte macrophage colony forming and not to granulocytes. Experimental Hematology. 12(6). 370. 2 indexed citations
18.
Hortobagyi, G. N., H. Y. Yap, George R. Blumenschein, et al.. (1978). Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.. PubMed. 62(11). 1685–92. 9 indexed citations
19.
Gutterman, J. U., E. M. Hersh, & Robert S. Benjamin. (1977). An effective new chemoimmunotherapy regimen for disseminated malignant melanoma (DMM). Proceedings of the American Association for Cancer Research. 18. 9 indexed citations
20.
Hersh, E. M., et al.. (1975). Surface proteins of human acute myelogenous leukemia (AML) cells. Federation Proceedings. 34(3). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Symann Breakdown of academic impact, for papers by William H. Knospe Breakdown of academic impact, for papers by M. Andreeff Breakdown of academic impact, for papers by C. De Wolf‐Peeters Breakdown of academic impact, for papers by P Hervé Breakdown of academic impact, for papers by Markus Wiesneth Breakdown of academic impact, for papers by Alexander Kiani Breakdown of academic impact, for papers by MF Greaves Breakdown of academic impact, for papers by Paul G. Schlegel Breakdown of academic impact, for papers by H. Poliwoda
Rankless by CCL
2026